Mr. Davis of North Carolina (for himself and Mr. Pfluger) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
To amend titles XVIII and XIX of the Social Security Act to provide that priority research drugs shall not be treated as line extensions of existing drugs for purposes of calculating manufacturer rebates under the Medicare and Medicaid programs, and for other purposes.
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Old Drugs, New Cures Act. H.R. 2542. 119th
Cong., 1st
sess., Introduced in House April 1, 2025. https://www.govinfo.gov/app/details/BILLS-119hr2542ih.
APA
Congress, House of Representatives (2025, April 1). Old Drugs, New Cures Act (H.R. 2542 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr2542ih.
MLA
United States, Congress, House of Representatives. Old Drugs, New Cures Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr2542ih. 119th Congress, H.R. 2542, Introduced in House 1 Apr. 2025.
Bluebook
H.R.2542 - 119th Congress (2025-2026): Old Drugs, New Cures Act, H.R.2542, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119hr2542ih.
